Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Castle Biosciences

NASDAQ CSTL
$24.24 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 27 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

666.24M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
568.53M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.57
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
27.49M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
12.33 %

Upcoming events Castle Biosciences

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Castle Biosciences

Stock analysis Castle Biosciences

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-21.63 28.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
1.70 4.35
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-19.51 10.00
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
3.35 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-7.65 7.67

Price change Castle Biosciences per year

43.37$ 107.69$
Min Max

Summary analysis Castle Biosciences

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Castle Biosciences

Revenue and net income Castle Biosciences

All parameters

Stock news Castle Biosciences

All news
3 November 2023 в 18:30

Castle Biosciences Shares Rise 11% on Discovering Data for Potential Complementary Tests

3 November 2023 в 18:25

Castle Biosciences Shares Rise 11% on Discovering Data for Potential Complementary Tests

7 July 2023 в 16:15

Castle Biosciences Shares Surge 33% on New Cancer Gene Risk Test Data

7 July 2023 в 16:15

Castle Biosciences Shares Surge 33% on New Cancer Gene Risk Test Data

9 August 2022 в 20:36

Castle Biosciences Shares Up 9% as Company Raises 2022 Revenue View

9 August 2022 в 20:36

Castle Biosciences Shares Up 9% as Company Raises 2022 Revenue View

9 August 2022 в 01:40

Castle Biosciences Raises 2022 Revenue Guidance, Shares Up 12%

9 August 2022 в 01:40

Castle Biosciences Raises 2022 Revenue Guidance, Shares Up 12%

5 April 2022 в 18:40

Castle Biosciences Shares Fall 12% Following AltheaDx Acquisition Agreement

5 April 2022 в 18:40

Castle Biosciences Shares Fall 12% Following AltheaDx Acquisition Agreement

11 November 2021 в 15:10

What’s Next For Castle Biosciences Stock?

About company Castle Biosciences

Castle Biosciences, Inc., a commercial-stage dermatological cancer company, focuses to provide diagnostic and prognostic solutions for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify high-risk patients with stage I and II melanomas based on biological information from 31 genes within their tumor tissue. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients with uveal melanoma, a rare eye cancer; DecisionDx-SCC, a proprietary 40-gene expression profile test that uses an individual patient's tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors; and DecisionDx DiffDx-Melanoma, a proprietary GEP test for suspicious pigmented lesions. It offers test services through physicians and their patients. The company was founded in 2007 and is headquartered in Friendswood, Texas.
Address:
505 South Friendswood Drive, Friendswood, TX, United States, 77546
Company name: Castle Biosciences
Issuer ticker: CSTL
ISIN: US14843C1053
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-07-25
Sector: Healthcare
Industry: Biotechnology
Site: https://castlebiosciences.com

On which stock exchange are Castle Biosciences (CSTL) stocks traded?

Castle Biosciences (CSTL) stocks are traded on NASDAQ.

What is the ticker of Castle Biosciences stocks (CSTL)?

The stock ticker of Castle Biosciences’s stocks or in other words, the code is CSTL. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Castle Biosciences (CSTL) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Castle Biosciences (CSTL) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Castle Biosciences (CSTL) stocks traded?

Castle Biosciences (CSTL) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Castle Biosciences (CSTL) stocks today?

The current price of Castle Biosciences stocks on 20.05.2024 is 24.24 dollars. per share.

What is the dynamics of Castle Biosciences (CSTL) stocks from the beginning of the year?

Castle Biosciences (CSTL) quotes have increased by 10.38% from the beginning of the year up to 24.24 dollars. per 1 stocks.

How much did Castle Biosciences (CSTL) stocks increase in мае 2024?

This month Castle Biosciences (CSTL) quotes have increased by 10.08% to 24.24 dollars. per share.

How much are Castle Biosciences (CSTL) stocks worth?

Today, on October, 20.05.2024 Castle Biosciences’s (CSTL) stocks cost 24.24 dollars..

What is the market capitalization of Castle Biosciences (CSTL)?

Capitalization is the market value of Castle Biosciences (CSTL) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.05.2024, the market capitalization of Castle Biosciences (CSTL) is estimated at about 666236400 dollars.